Synthorx gains following $131M IPO

Synthetic biology company Synthorx Inc. (NASDAQ:THOR) gained $1.61 (15%) to $12.61 on Dec. 7 after raising $131 million late Dec. 6 through the sale of 11.9 million shares at $11 in its bumped-up IPO. The offering values the company at $332.5 million.

In November, Synthorx amended the offering to sell 9.1 million shares at $10-$12. At the midpoint of that range, the company would have raised $100 million with a corresponding valuation of $302 million. ...